Literature DB >> 33008627

Site-Specific Recombination - How Simple DNA Inversions Produce Complex Phenotypic Heterogeneity in Bacterial Populations.

Dominika Trzilova1, Rita Tamayo2.   

Abstract

Many bacterial species generate phenotypically heterogeneous subpopulations as a strategy for ensuring the survival of the population as a whole - an environmental stress that eradicates one subpopulation may leave other phenotypic groups unharmed, allowing the lineage to continue. Phase variation, a process that functions as an ON/OFF switch for gene expression, is one way that bacteria achieve phenotypic heterogeneity. Phase variation occurs stochastically and reversibly, and in the presence of a selective pressure the advantageous phenotype(s) predominates in the population. Phase variation can occur through multiple genetic and epigenetic mechanisms. This review focuses on conservative site-specific recombination that generates reversible DNA inversions as a genetic mechanism mediating phase variation. Recent studies have sparked a renewed interest in phase variation mediated through DNA inversion, revealing a high level of complexity beyond simple ON/OFF switching, including unusual modes of gene regulation, and highlighting an underappreciation of the use of these mechanisms by bacteria.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33008627      PMCID: PMC7755746          DOI: 10.1016/j.tig.2020.09.004

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  94 in total

Review 1.  Lewis antigens in Helicobacter pylori: biosynthesis and phase variation.

Authors:  G Wang; Z Ge; D A Rasko; D E Taylor
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

2.  Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli.

Authors:  M S McClain; I C Blomfield; B I Eisenstein
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

3.  A family of phase-variable restriction enzymes with differing specificities generated by high-frequency gene rearrangements.

Authors:  K Dybvig; R Sitaraman; C T French
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

4.  Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.

Authors:  J O Kim; J N Weiser
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

5.  The control mechanism of opacity protein expression in the pathogenic Neisseriae.

Authors:  K Muralidharan; A Stern; T F Meyer
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

6.  Invertible promoters mediate bacterial phase variation, antibiotic resistance, and host adaptation in the gut.

Authors:  Xiaofang Jiang; A Brantley Hall; Timothy D Arthur; Damian R Plichta; Christian T Covington; Mathilde Poyet; Jessica Crothers; Peter L Moses; Andrew C Tolonen; Hera Vlamakis; Eric J Alm; Ramnik J Xavier
Journal:  Science       Date:  2019-01-11       Impact factor: 47.728

Review 7.  Slipped-strand mispairing: a major mechanism for DNA sequence evolution.

Authors:  G Levinson; G A Gutman
Journal:  Mol Biol Evol       Date:  1987-05       Impact factor: 16.240

8.  Serum and urogenital antibody responses to Escherichia coli pili in cystitis.

Authors:  P Rene; M Dinolfo; F J Silverblatt
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

9.  Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.

Authors:  J O Kim; S Romero-Steiner; U B Sørensen; J Blom; M Carvalho; S Barnard; G Carlone; J N Weiser
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

10.  Characterization of the SigD regulon of C. difficile and its positive control of toxin production through the regulation of tcdR.

Authors:  Imane El Meouche; Johann Peltier; Marc Monot; Olga Soutourina; Martine Pestel-Caron; Bruno Dupuy; Jean-Louis Pons
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

View more
  7 in total

Review 1.  Mastering the control of the Rho transcription factor for biotechnological applications.

Authors:  Tomás G Villa; Ana G Abril; Angeles Sánchez-Pérez
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-08       Impact factor: 4.813

2.  Coordinated modulation of multiple processes through phase variation of a c-di-GMP phosphodiesterase in Clostridioides difficile.

Authors:  Leila M Reyes Ruiz; Kathleen A King; Christian Agosto-Burgos; Isabella S Gamez; Nicole C Gadda; Elizabeth M Garrett; Rita Tamayo
Journal:  PLoS Pathog       Date:  2022-07-05       Impact factor: 7.464

Review 3.  Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.

Authors:  Shannon L Kordus; Audrey K Thomas; D Borden Lacy
Journal:  Nat Rev Microbiol       Date:  2021-11-26       Impact factor: 78.297

4.  Bacteroidales species in the human gut are a reservoir of antibiotic resistance genes regulated by invertible promoters.

Authors:  Wei Yan; A Brantley Hall; Xiaofang Jiang
Journal:  NPJ Biofilms Microbiomes       Date:  2022-01-10       Impact factor: 8.462

5.  Multiple Regulatory Mechanisms Control the Production of CmrRST, an Atypical Signal Transduction System in Clostridioides difficile.

Authors:  Elizabeth M Garrett; Anchal Mehra; Ognjen Sekulovic; Rita Tamayo
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.867

6.  Flagellum and toxin phase variation impacts intestinal colonization and disease development in a mouse model of Clostridioides difficile infection.

Authors:  Dominika Trzilova; Mercedes A H Warren; Nicole C Gadda; Caitlin L Williams; Rita Tamayo
Journal:  Gut Microbes       Date:  2022 Jan-Dec

7.  PaReBrick: PArallel REarrangements and BReaks identification toolkit.

Authors:  Alexey Zabelkin; Yulia Yakovleva; Olga Bochkareva; Nikita Alexeev
Journal:  Bioinformatics       Date:  2021-10-03       Impact factor: 6.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.